12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Shattuck Labs (STTK) saw a substantial increase of 92.9%, while Reshape Lifesciences (RSLS) rose by 51.19%. Other gainers included Inhibikase Therapeutics (IKT), C4 Therapeutics (CCCC), LifeMD (LFMD), and Nemaura Medical (NMRD). Conversely, Motus GI Holdings (MOTS), Pasithea Therapeutics (KTTA), Relay Therapeutics (RLAY), Aptevo Therapeutics (APVO), Jaguar Health (JAGX), and Aclarion (ACON) all saw their stock prices fall.
December 13, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aclarion's shares decreased by 8.5% to $0.21, with a market cap of $1.8 million.
ACON's pre-market fall could be indicative of a bearish sentiment, potentially affecting its stock price negatively in the short term.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Aptevo Therapeutics' stock declined by 8.75% to $0.17, with a market cap of $2.9 million.
APVO's pre-market decline could signal a negative trend that might affect its stock price in the short term.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Jaguar Health's shares decreased by 8.51% to $0.15, with a market cap of $7.8 million.
The pre-market decrease in JAGX's stock price may lead to a negative short-term impact as the market opens.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Pasithea Therapeutics' stock declined by 10.72% to $0.4, with a market cap of $8.2 million.
KTTA's pre-market decrease may reflect investor concerns, which could lead to further short-term declines in its stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Motus GI Holdings' shares fell 12.4% to $3.1, with a market cap of $2.1 million.
The decline in MOTS's stock price during pre-market trading could indicate negative sentiment, potentially leading to a short-term downtrend.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Relay Therapeutics' shares fell 9.87% to $8.59, with a market cap of $1.0 billion.
The significant pre-market drop in RLAY's stock price suggests a bearish outlook that may continue into the short-term market session.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
C4 Therapeutics' stock increased by 18.8% to $2.78, with a market cap of $137.0 million.
The pre-market growth for CCCC could indicate a positive short-term trajectory as the market responds to the uptick.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Inhibikase Therapeutics' shares rose by 20.83% to $1.45, with a market cap of $8.9 million.
IKT's notable pre-market increase may attract investor attention, potentially leading to short-term price momentum.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
LifeMD's stock moved upwards by 17.28% to $9.5, with a market cap of $360.7 million.
LFMD's pre-market increase may suggest investor optimism, possibly leading to a short-term positive impact on its stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Nemaura Medical's stock rose 11.32% to $0.19, with a market cap of $5.6 million.
The pre-market rise in NMRD's stock price could be a positive sign for short-term price action as the market opens.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences' stock jumped by 51.19% to $0.38, with a market cap of $4.9 million.
The significant pre-market rise in RSLS's stock price indicates potential investor confidence, which may lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Shattuck Labs' stock soared by 92.9% in pre-market trading, with a market cap of $172.9 million.
The substantial pre-market increase in STTK's stock price suggests a strong positive sentiment that could lead to a short-term uptrend as the market opens.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100